YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Sun Pharmaceutical Industries

Sun Pharmaceutical Industries

BSE: 524715|NSE: SUNPHARMA|ISIN: INE044A01036|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jun 22, 16:00
666.45
-4.8 (-0.72%)
VOLUME 205,114
LIVE
NSE
Jun 22, 16:00
666.80
-4.55 (-0.68%)
VOLUME 4,577,152
News on Sun Pharmaceutical Industries
Select Year: 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Sun Pharma enters patent litigation settlement with Celgene for launch of generic Revlimid

9.24 am | 22 Jun 2021 |  Source: Moneycontrol.com

As per the terms of the settlement, Celgene will grant Sun Pharma a license to Celgene’s patents required to manufacture and sell certain limited qu...

Buy Sun Pharmaceutical Industries; target of Rs 783: Geojit

2.27 pm | 04 Jun 2021 |  Source: Moneycontrol.com

Geojit is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 783 in its research report dated ...

Hold Sun Pharmaceutical Industries; target of Rs 700: ICICI Direct

10.34 am | 01 Jun 2021 |  Source: Moneycontrol.com

ICICI Direct recommended hold rating on Sun Pharmaceutical Industries with a target price of Rs 700 in its research report dated May 28, 2021....

Hold Sun Pharma; target of Rs 720: Emkay Global Financial

5.38 pm | 31 May 2021 |  Source: Moneycontrol.com

Emkay Global Financial recommended hold rating on Sun Pharma with a target price of Rs 720 in its research report dated May 28, 2021....

Buy Sun Pharmaceutical Industries: target of Rs 810: Sharekhan

1.38 pm | 31 May 2021 |  Source: Moneycontrol.com

Sharekhan is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 810 in its research report dat...

Buy Sun Pharma; target of Rs 830: Motilal Oswal

12.35 pm | 31 May 2021 |  Source: Moneycontrol.com

Motilal Oswal is bullish on Sun Pharma recommended buy rating on the stock with a target price of Rs 830 in its research report dated May 28, 2021....

Sun Pharma: Traction in speciality likely to sustain

10.53 am | 31 May 2021 |  Source: Moneycontrol.com

Sun Pharma's key specialty products, particularly Ilumya (plaque psoriasis) and Cequa (dry eye disease), held up well...

Sun Pharma joins biosimilars race, to target assets with patent expiries in 7-10 years

4.08 pm | 28 May 2021 |  Source: Moneycontrol.com

Company chief Dilip Shanghvi, known for his midas touch in the pharma industry, has for years stayed away from biosimilars but now aims to spend betwe...

Sun Pharma Consolidated March 2021 Net Sales at Rs 8,522.98 crore, up 4.13% Y-o-Y

2.25 pm | 28 May 2021 |  Source: Moneycontrol.com

NULL...

Sun Pharma Standalone March 2021 Net Sales at Rs 3,159.64 crore, up 11.41% Y-o-Y

2.00 pm | 28 May 2021 |  Source: Moneycontrol.com

NULL...

Buy Sun Pharmaceutical; target of Rs 786: Dolat Capital Market

12.44 pm | 28 May 2021 |  Source: Moneycontrol.com

Dolat Capital Market is bullish on Sun Pharmaceutical has recommended buy rating on the stock with a target price of Rs 786 in its research report dat...

What should investors do with Sun Pharma post Q4 earnings: buy, sell or hold?

9.40 am | 28 May 2021 |  Source: Moneycontrol.com

Here is what brokerages have to say about the stock and the company after the March quarter earnings announcement:...

Sun Pharma to announce Q4 results today; here what brokerages expect

8.43 am | 27 May 2021 |  Source: Moneycontrol.com

The pharma major is likely to report a more than 100 percent year-on-year growth in profit, backed by healthy operating performance, and low base in t...

Dilip Shanghvi resigns as MD of SPARC: Here's what you need to know about him

3.55 pm | 26 May 2021 |  Source: Moneycontrol.com

Dilip Shanghvi will continue to be SPARC's chairman and a non-executive director on the board....

Govt to import 6.8 lakh vials of Amphotericin-B injections in May, June; domestic production ramped up to 2.6 lakh vials

3.09 pm | 21 May 2021 |  Source: Moneycontrol.com

The government said in May 2021, 3,63,000 vials of Amphotericin-B will be imported, thereby resulting in total availability in the country inclusive o...

Sun Pharma appoints Pawan Goenka, Rama Bijapurkar as additional independent directors

2.59 pm | 21 May 2021 |  Source: Moneycontrol.com

The board of directors of Sun Pharma approved the appointment of Goenka and Bijapurkar as additional independent directors on the board of the company...

Pharma firms scramble to boost production of antifungal jab Amphotericin B as Black Fungus cases rise

9.52 pm | 18 May 2021 |  Source: Moneycontrol.com

Industry sources told Moneycontrol that it would take at least 15-30 days for new production to reach pharmacy shelves. The drug is complex to manufac...

Sun Pharma Q4 PAT seen up 82.2% YoY to Rs. 1,462.7 cr: Sharekhan

8.40 pm | 12 Apr 2021 |  Source: Moneycontrol.com

Net Sales are expected to increase by 6.2 percent Y-o-Y (down 1.6 percent Q-o-Q) to Rs. 8,692.6 crore, according to Sharekhan....

Buy Sun Pharmaceutical Industries: target of Rs 700: Sharekhan

2.19 pm | 05 Apr 2021 |  Source: Moneycontrol.com

Sharekhan is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 700 in its research report dat...

Quant Pick - Sun Pharmaceuticals: ICICI Direct

1.39 pm | 05 Mar 2021 |  Source: Moneycontrol.com

According to ICICI Direct, Buy Sun Pharmaceuticals in range of Rs 625-635 Target: Rs 738 Stop Loss: Rs 570 Time frame: Three months....

1 2
Quick Links for Sun Pharmaceutical Industries
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.